Tumor-infiltrating CCR2(+) inflammatory monocytes counteract specific immunotherapy

Date Published

September 30, 2023

Bartneck J, Hartmann AK, Stein L, Arnold-Schild D, Klein M, Stassen M, Marini F, Pielenhofer J, Meiser SL, Langguth P, Mack M, Muth S, Probst HC, Schild H, Radsak MP. Tumor-infiltrating CCR2(+) inflammatory monocytes counteract specific immunotherapy. Front Immunol. 2023 14:1267866. doi:10.3389/fimmu.2023.1267866. PMID: 37849753